做多
ZOM - Mainly based on Fundamental Analysis
Zomedica Pharmaceuticals (NYSEMKT:ZOM) has priced a public offering of ~133.3M common shares, together with warrants to purchase up to same number of common shares, at a combined price of $0.15/share and accompanying warrant, for expected gross proceeds of ~$20M.
Two-year warrants have an exercise price of $0.15/share.
Net proceeds will be used for the development of TRUFORMA diagnostic platform, including making milestone payments, working capital and other general corporate purposes.
Closing date is May 29
Two-year warrants have an exercise price of $0.15/share.
Net proceeds will be used for the development of TRUFORMA diagnostic platform, including making milestone payments, working capital and other general corporate purposes.
Closing date is May 29
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。